A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Thursday, April 27 | 11 am-12 p.m. ET | Online CDC Webinar: Coronary Heart Disease, Family History and Public Health: From Familial Hypercholesterolemia to Elevated Lipoprotein A Heart disease remains […]
Thursday, April 27 | 12-1 p.m. ET | Online The Duke Precision Medicine Program Forum Series features speakers from Duke and beyond working on innovative research in clinical, translational, and […]
GMKB